Inhibitors of the renin-angiotensin system in established cardiac failure.
作者信息
Chatterjee K
机构信息
Department of Cardiology, School of Medicine, University of California at San Francisco 94080-5006, USA.
出版信息
Heart. 1996 Nov;76(3 Suppl 3):83-91. doi: 10.1136/hrt.76.3_suppl_3.83.
Abstract
摘要
相似文献
1
Inhibitors of the renin-angiotensin system in established cardiac failure.已确诊心力衰竭患者中肾素-血管紧张素系统抑制剂
Heart. 1996 Nov;76(3 Suppl 3):83-91. doi: 10.1136/hrt.76.3_suppl_3.83.
2
[Angiotensin-converting enzyme (ACE) inhibitors in cardiac decompensation; from randomized study to individual patient].
Ned Tijdschr Geneeskd. 1992 Sep 12;136(37):1796-8.
3
[Peripheral and cardiac adaptive mechanisms in heart failure: the role of the renin-angiotensin system and its inhibition].
Verh Dtsch Ges Inn Med. 1991;97:552-7.
4
5
Role of angiotensin-converting enzyme inhibitors in congestive heart failure.血管紧张素转换酶抑制剂在充血性心力衰竭中的作用。
Heart Lung. 1990 Sep;19(5 Pt 1):505-11.
6
Angiotensin-converting enzyme inhibitors in heart failure.
Med Clin North Am. 1989 Mar;73(2):315-38. doi: 10.1016/s0025-7125(16)30675-7.
7
Angiotensin-converting enzyme inhibitors.血管紧张素转换酶抑制剂
Crit Care Nurse. 1990 Mar;10(3):74-7.
8
[The role of angiotensin converting enzyme inhibition for therapy of patients with hypertension and heart failure].[血管紧张素转换酶抑制剂在高血压合并心力衰竭患者治疗中的作用]
Cardiology. 1993;82 Suppl 1:3-19. doi: 10.1159/000175900.
9
[ACE inhibitors in hypertension and heart failure].[血管紧张素转换酶抑制剂在高血压和心力衰竭中的应用]
Internist (Berl). 1992 Oct;33(10):639-44.
本文引用的文献
1
Coronary flow reserve in patients with dilated cardiomyopathy.扩张型心肌病患者的冠状动脉血流储备
Am Heart J. 1993 Jan;125(1):93-8. doi: 10.1016/0002-8703(93)90061-d.
2
Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies.选择性血管紧张素II受体拮抗剂和血管紧张素转换酶抑制剂对体内冠状动脉血管系统的影响。血管内二维和多普勒超声研究。
Circulation. 1993 Mar;87(3):931-8. doi: 10.1161/01.cir.87.3.931.
3
Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group.
Circulation. 1995 Feb 1;91(3):691-7. doi: 10.1161/01.cir.91.3.691.
4
Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography.扩张型心肌病无明显心力衰竭患者对起搏性心动过速和双嘧达莫输注的心肌血流反应。正电子发射断层扫描定量评估。
Circulation. 1995 Aug 15;92(4):796-804. doi: 10.1161/01.cir.92.4.796.
5
Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.氯沙坦与依那普利对中重度慢性心力衰竭患者临床状况及运动能力影响的比较
J Am Coll Cardiol. 1995 Aug;26(2):438-45. doi: 10.1016/0735-1097(95)80020-h.
6
Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.卡托普利对慢性心力衰竭的血流动力学及心肌代谢的影响
Br Heart J. 1982 Mar;47(3):233-8. doi: 10.1136/hrt.47.3.233.
7
Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.长期使用卡托普利治疗重度慢性心力衰竭时的血流动力学反应模式。
Circulation. 1983 Oct;68(4):803-12. doi: 10.1161/01.cir.68.4.803.
8
Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations.依那普利：一种用于慢性心力衰竭的新型血管紧张素转换酶抑制剂：急性和慢性血流动力学评估
J Am Coll Cardiol. 1983 Nov;2(5):865-71. doi: 10.1016/s0735-1097(83)80233-2.
9
Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.口服血管紧张素转换酶抑制剂可使慢性心力衰竭患者即刻并持续出现血流动力学及临床改善。
Circulation. 1980 May;61(5):931-7. doi: 10.1161/01.cir.61.5.931.
10
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.血管扩张剂疗法对慢性充血性心力衰竭死亡率的影响。退伍军人管理局合作研究的结果。
N Engl J Med. 1986 Jun 12;314(24):1547-52. doi: 10.1056/NEJM198606123142404.
Zotero 插件